Answers are grounded in this paper and cite their sources.
Objective To compare the PBMC proteome of patients with nAMD and an inadequate response to aflibercept, relative to controls without retinal pathology, with two published monocyte transcriptomic datasets, in order to quantify gene- and pathway-level concordance across molecular layers and to identify features shared across datasets. Participants and controls Twelve patients with nAMD and an inadequate response to aflibercept and 9 controls without retinal pathology were included. For cross-omic comparison, two public monocyte transcriptomic datasets were used: GSE76237, including 14 treatment-naïve patients with nAMD and 15 age-matched controls, and GSE222647, including 27 previously treated patients with nAMD stratified by anti-VEGF treatment burden (15 low-burden and 12 high-burden patients). Methods Proteomics PBMCs were profiled by data-independent acquisition LC/MS-MS. Differential abundance was assessed with limma, followed by network clustering and functional enrichment analysis. The proteomic signature was compared at gene and pathway (Hallmark) level with 2 public monocyte transcriptomic datasets: single-cell RNA sequencing (GSE222647) and microarray (GSE76237). Main outcome measures Differentially abundant protein groups and enriched pathways; overlap and directional concordance of genes and Hallmark pathways between the proteomic and transcriptomic datasets. Results Network clustering and functional enrichment consistently indicated changes in proteins of the transcription, mRNA splicing and translation machinery, together with altered abundance of mitochondrial proteins, including SMDT1 and TOMM subunits. Cross-omic comparison identified 10 and 24 genes shared with the scRNA-seq and microarray datasets, respectively, numbers consistent with chance, with directional concordance of 3/10 and 13/24. Log 2 fold changes were essentially uncorrelated across layers, and CD82 and TAOK2, the only genes shared across all three datasets, showed inconsistent direction. Hallmark enrichment scores showed no correlation across layers (15 of 48 pathways concordant). Conclusions Relative to controls without retinal pathology, the PBMC proteome of patients with nAMD and an inadequate response to aflibercept showed changes in the gene-expression machinery and altered abundance of mitochondrial proteins. This signature was not reflected in monocyte transcriptomic data. These exploratory findings identify SMDT1 and TOMM subunits as candidates for targeted validation in cohorts including patients with an adequate response to anti-VEGF therapy.
No takes yet. Share an insight, caveat, or question.
Castro-Fernández et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: